| P2093 | author name string | Valter Duro Garcia | |
| | Elizete Keitel | |
| | Jorge Neumann | |
| | Jamile Abud | |
| | Andre Kohatsu Coutinho | |
| | Cynthia Keitel da Silva | |
| | Damaris Mikaela Balin Dorsdt | |
| | Gisele Meinerz | |
| | Juliana Montagner | |
| | Rosana Mussoi Bruno | |
| P2860 | cites work | Expanded criteria donors for kidney transplantation. | Q35106631 |
| | Humoral theory of transplantation | Q35142603 |
| | Revisiting traditional risk factors for rejection and graft loss after kidney transplantation | Q35250310 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death | Q43829027 |
| | Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation | Q44418324 |
| | Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. | Q44533720 |
| | Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 |
| | Impact of the presence and duration of donor-specific antibodies on renal function | Q46245832 |
| | HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies | Q46716771 |
| | Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. | Q47726666 |
| | Brazilian Chronic Dialysis Survey 2016. | Q47770414 |
| | Significance of the positive crossmatch test in kidney transplantation | Q47800073 |
| | Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant | Q47989417 |
| | Differential effects of donor-specific HLA antibodies in living- versus deceased-donor transplantation. | Q49719376 |
| | Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. | Q50946246 |
| | HLA antibody identification with single antigen beads compared to conventional methods. | Q51303028 |
| | Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients. | Q53654083 |
| | Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. | Q53659700 |
| | Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. | Q53861449 |
| | Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China | Q57489270 |
| | Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation | Q61717674 |
| | Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation | Q82732578 |
| | Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation in a Brazilian center | Q87599336 |
| P304 | page(s) | 101212 | |
| P577 | publication date | 2019-06-27 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Late impact of preformed anti-HLA antibodies on kidney graft outcome | |
| P478 | volume | 55 | |